首页> 外文期刊>Applied biochemistry and microbiology >Efficient Inhibition of Some Multi-Drug Resistant Pathogenic Bacteria by Bioactive Metabolites from Bacillus amyloliquefaciens S5I4 Isolated from Archaeological Soil in Egypt
【24h】

Efficient Inhibition of Some Multi-Drug Resistant Pathogenic Bacteria by Bioactive Metabolites from Bacillus amyloliquefaciens S5I4 Isolated from Archaeological Soil in Egypt

机译:埃及考古土壤中分离的解淀粉芽孢杆菌S5I4的生物活性代谢物对某些多药耐药病原菌的有效抑制作用

获取原文
获取原文并翻译 | 示例
           

摘要

Sixty-eight bacterial cultures were isolated from 5 archaeological soils in Egypt. It is necessary to characterize bacteria from ancient temples to develop protection programs for such archaeological places. Purified bacterial cultures were then tested for their capability to inhibit some multi-drug resistant (MDR) pathogenic bacteria including Staphylococcus aureus, Listeria monocytogenes, Bacillus cereus, Escherichia coli and Klebsiella pneumoniae. Among the most active 10 antibacterial isolates, only one isolate designated as S5I4 was selected, characterized and identified as belonging to Bacillus amyloliquefaciens. The strain identification was confirmed by amplification of its 16S rRNA gene. The partial nucleotide sequence of the amplified 16S rRNA gene of the tested strain was submitted in GenBank with accession number AB813716. The physical and nutritional parameters were optimized to improve the production of antimicrobial agents by the B. amyloliquefaciens S5I4. The maximum antagonistic effect of this strain against the tested MDR pathogenic bacteria was achieved in presence of 1% galactose and 0.5% yeast extract at 37A degrees C and pH 7.0 after 48 h incubation. The antibacterial compounds of B. amyloliquefaciens S5I4 were extracted, purified and characterized using spectroscopic analysis (IR, UV, proton NMR and MS). The compound having inhibitory activity was identified as butanedioic acid, octadecyl,1(1carboxy1methylethyl) 4octyl ester.
机译:从埃及的5个考古土壤中分离出68个细菌培养物。有必要对古代寺庙中的细菌进行鉴定,以开发针对此类考古场所的保护计划。然后测试纯化的细菌培养物抑制某些多药耐药(MDR)致病菌的能力,包括金黄色葡萄球菌,单核细胞增生李斯特菌,蜡样芽孢杆菌,大肠杆菌和肺炎克雷伯菌。在活性最高的10种细菌分离物中,仅选择,命名和鉴定出一种属于淀粉芽孢杆菌的分离株,命名为S5I4。通过扩增其16S rRNA基因证实了菌株的鉴定。待测菌株的扩增的16S rRNA基因的部分核苷酸序列已提交GenBank,登录号为AB813716。优化了物理和营养参数,以提高解淀粉芽孢杆菌S5I4产生抗菌剂的能力。温育48小时后,在37°C和pH 7.0下,存在1%半乳糖和0.5%酵母提取物的情况下,此菌株对测试的MDR病原菌具有最大的拮抗作用。提取,纯化和使用光谱分析(IR,UV,质子NMR和MS)表征B. amyloliquefaciens S5I4的抗菌化合物。具有抑制活性的化合物被鉴定为丁二酸,十八烷基,1(1羧基1甲基乙基)4-辛基酯。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号